about
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targetsTargeting leukocyte trafficking for the treatment of inflammatory bowel disease.Natalizumab in the treatment of Crohn's disease patients.Evaluation of tert-butyl isosteres: case studies of physicochemical and pharmacokinetic properties, efficacies, and activities.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vercirnon for the treatment of Crohn's disease.
@en
type
label
Vercirnon for the treatment of Crohn's disease.
@en
prefLabel
Vercirnon for the treatment of Crohn's disease.
@en
P2860
P1476
Vercirnon for the treatment of Crohn's disease.
@en
P2093
Fabio Cominelli
Kristen O Arseneau
P2860
P304
P356
10.1517/13543784.2013.795946
P407
P577
2013-04-30T00:00:00Z